Nisa Investment Advisors’s Trevi Therapeutics TRVI Stock Holding History

Nisa Investment Advisors’s Portfolio TRVI Stock Details TRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$71.6K	Buy	3,839 +333	+9%	+$4.84K	﹤0.01%	1708
2026 Q1	$41.8K	Buy	3,506 +2,607	+290%	+$29.2K	﹤0.01%	1745
2025 Q4	$11.3K	Buy	899 +730	+432%	+$8.44K	﹤0.01%	2164
2025 Q3	$1.55K	Hold	169	–	–	﹤0.01%	2666
2025 Q2	$924	Hold	169	–	–	﹤0.01%	2751
2025 Q1	$1.06K	Buy	+169	New	+$806	﹤0.01%	2625
2024 Q4	–	Sell	-84	Closed	-$281	–	3057
2024 Q3	$281	Buy	84 +81	+2,700%	+$241	﹤0.01%	2809
2024 Q2	$9	Hold	3	–	–	﹤0.01%	2932
2024 Q1	$10	Buy	+3	New	+$7	﹤0.01%	2794

Other funds holding TRVI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nisa Investment Advisors's TRVI Position: Q2 2026 in Review

Nisa Investment Advisors increased its Trevi Therapeutics (TRVI) stake by 9.5% in Q2 2026, buying an estimated $4.84K and bringing the position to 3,839 shares worth $71.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

Nisa Investment Advisors first reported a position in TRVI in Q1 2024 and has held it in 9 quarters since. 72 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

Nisa Investment Advisors held 3,839 shares of Trevi Therapeutics worth $71.6K as of Q2 2026.
Nisa Investment Advisors bought 333 Trevi Therapeutics shares in Q2 2026, an estimated $4.84K.
Trevi Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1708 holding.
Nisa Investment Advisors first reported a position in Trevi Therapeutics in Q1 2024 and has held it in 9 quarters since.
72 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.